James D. Brooks

Publication Details

  • Gene expression profiling predicts survival in conventional renal cell carcinoma.

    Zhao H, Ljungberg B, Grankvist K, Rasmuson T, Tibshirani R, Brooks JD. PLoS Med. 2006; 3 (1): e13

    Conventional renal cell carcinoma (cRCC) accounts for most of the deaths due to kidney cancer. Tumor stage, grade, and patient performance status are used currently to predict survival after surgery. Our goal was to identify gene expression features, using comprehensive gene expression profiling, that correlate with survival.

    PubMedID: 16318415

Stanford Medicine Resources:

Footer Links: